Stay updated on Long Term Inclisiran in High CV Risk Clinical Trial
Sign up to get notified when there's something new on the Long Term Inclisiran in High CV Risk Clinical Trial page.

Latest updates to the Long Term Inclisiran in High CV Risk Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new release tag Revision: v3.6.6 appeared in the history, replacing the previous Revision: v3.6.5. This indicates an updated version of the page’s release notes/UI for the record history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe revision history shows a new build label, updating from v3.6.4 to v3.6.5. This represents a background release rather than changes to study data or visible content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe footer now shows Revision: v3.6.4 instead of v3.6.3, indicating a new site release. This updates the version label displayed on the page without altering the study information shown.SummaryDifference0.1%

- Check78 days agoChange DetectedThe record shows a new revision label: v3.6.3 replacing v3.6.2, indicating a minor software release of the site interface. This update is limited to the UI/version and does not modify study data or historical records.SummaryDifference0.1%

- Check85 days agoChange DetectedThe revision history now includes a new entry labeled v3.6.2, indicating an update to the study record; the prior revision v3.6.0 has been removed from the visible history.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded a recruitment status indicating the study is no longer looking for participants, signaling that enrollment has ended. The history also introduces a new revision tag (v3.6.0) and removes the prior revision entry (v3.5.5).SummaryDifference0.3%

Stay in the know with updates to Long Term Inclisiran in High CV Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Inclisiran in High CV Risk Clinical Trial page.